Efficacy and safety of peptide receptor radionuclide therapy in advanced radioiodine-refractory differentiated thyroid cancer and metastatic medullary thyroid cancer: a systematic review

BACKGROUND: It has been shown that a subgroup of patients with differentiated thyroid cancer (DTC) and medullary thyroid carcinoma (MTC) would progress to advanced stages of thyroid cancer. Therefore, the present study was done to systematically review available evidence in order to investigate effi...

Descripción completa

Detalles Bibliográficos
Autores principales: Maghsoomi, Zohreh, Emami, Zahra, Malboosbaf, Ramin, Malek, Mojtaba, Khamseh, Mohammad E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139052/
https://www.ncbi.nlm.nih.gov/pubmed/34016077
http://dx.doi.org/10.1186/s12885-021-08257-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139052/
https://www.ncbi.nlm.nih.gov/pubmed/34016077
http://dx.doi.org/10.1186/s12885-021-08257-x

Ejemplares similares